Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 206)
Posted On: 09/11/2017 1:05:40 PM
Post# of 72446
Avatar
Posted By: sox0407
Which drug will be partnered first? My money is on B-UP. From the PR,

"Furthermore, we are receiving significant interest in Brilacidin for inflammatory bowel disease following the successful completion of the Phase 2 proof-of-concept study of Brilacidin for ulcerative proctitis/ulcerative proctosigmoiditis. Ongoing dialogue under confidentiality agreements has us planning for additional studies on that front. "

http://www.ipharminc.com/press-release/2017/9...-agreement

Sounds to me like the additional studies will involve a partner. Today's blog touches on the challenges of different formulations, so I think IPIX needs BP's expertise and technology.

http://www.ipharminc.com/new-blog/2017/9/11/b...ation-work

"This can make drug formulation work, particularly the oral delivery (pdf) of medications , more challenging (e.g., see the FORMAMP Project)."

Interesting read on the FORMAMP Project.

"The FORMAMP project focuses on innovative nanoformulation design of antimicrobial and immunomodulatory peptides in order to increase their efficiency and stability."

http://formampproject.com/about-formamp/formamp-concept/













(2)
(0)






Dont-give-up.jpg



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site